Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-39 Cr₹-441 Cr₹-422 Cr₹818 Cr₹794 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-39 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-39 Cr
Mar2025₹-441 Cr
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-39 Cr
Negative
Mar2025 ₹-441 Cr
Negative
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,891.7 Cr 2.3% 4.9% -14.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,507.0 Cr 2.8% 7.4% 14.5% Stock Analytics
DIVIS LABORATORIES ₹190,744.0 Cr 6.4% 8.3% 0.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹168,250.0 Cr 2.1% 8.7% 47.7% Stock Analytics
CIPLA ₹116,213.0 Cr 0.5% 3.6% -5.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,980.0 Cr -7.6% -2.2% -5.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.3%

4.9%

-14.1%

SENSEX

-1.4%

4.4%

-7.6%


You may also like the below Video Courses